Objective: To evaluate interdevice reliability in body density (Db) and percent body fat (%BF) using air-displacement plethysmography, the BOD POD (BP) body composition system. Design and Setting: Duplicate body composition tests were performed in immediate succession on 50 adults (26 M, 24F; 21-53 y) using two BP units located in the same body composition laboratory. Results: Mean Db and %BF between BP1 and BP2 did not differ significantly for men (DDb ¼ 0.000370.0008 g/ml, P ¼ 0.632; D%BF ¼ 0.171.3, P ¼ 0.665), while for women, there were small but significant differences in Db and %BF between BP1 and BP2 (DDb ¼ 0.001870.0003 g/ml, P ¼ 0.001; D%BF ¼ 0.871.1, P ¼ 0.001). The regression between %BF by BP1 and BP2 did not deviate significantly from the line of identity for both men and women (R 2 ¼ 0.95, standard error of estimate (s.e.e.) ¼ 1.23 %BF for men; R 2 ¼ 0.97, s.e.e ¼ 1.13 %BF for women). Individual variations in %BF estimates between the two BP units were within acceptable ranges (95% limits of agreement ¼ À2.5-2.7 %BF for men; À1.4-3.0 %BF for women), and there was no trend in individual differences as %BF varied (r ¼ À0.19, P ¼ 0.359 for men; r ¼ 0.09, P ¼ 0.677 for women). Other subject characteristics, including age, body mass, height, and body mass index, did not significantly contribute to the differences in %BF estimates by the two BP units. Conclusions: No clinically significant differences in Db and %BF estimates exist between the BP units, and the interdevice variability of the BP has minimal impact on %BF estimates. Further, test-to-test reliability between BP units appears to be as good as within one unit.
Introduction
Air-displacement plethysmography (ADP) is a relatively new method used to estimate fat and fat-free mass. The method utilizes the same principles as the classic 'gold standard' method of hydrostatic weighing (HW), except ADP measures the amount of air that is displaced instead of water. Currently, the only ADP system commercially available is manufactured as the BOD POD s (BP) (Life Measurement, Inc., Concord, CA, USA). The BP offers several advantages over HW including a reduced time required to perform a test, improved ease of use for both subject and technician, and better accommodation of varying subject types (Fields et al, 2002) .
Overall accuracy of the BP appears to be good although some studies report discrepancies in percent body fat (%BF) estimates between the BP and reference methods. The majority of studies comparing the BP to HW report a mean difference of less than 1 %BF between the two methods (McCrory et al, 1995; Levenhagen et al, 1999; Fields et al, 2001) . The average reported standard error of estimate (s.e.e.) is 2.7 %BF (range ¼ 1.8-3.6 %BF) (McCrory et al, 1995; Collins et al, 1999; Fields et al, 2001) , which is classified as 'very good' by a subjective rating proposed by Lohman (1992) . In the few studies that have reported larger differences, there does not appear to be a systematic bias (Collins et al, 1999; Wagner & Heyward, 2000) . Comparisons against dual energy X-ray absorptiometry (DXA) have demonstrated similar results as with HW. These studies report mean %BF differences ranging from 0.5 to 3 %BF and s.e.e.s ranging from 2.4 to 3.5 %BF (Levenhagen et al, 1999; Wagner & Heyward, 2000; Weyers et al, 2002) .
Intradevice reliability of the BP for %BF estimates has been found to be as good, if not better than HW. McCrory et al (1995) observed that within-subject test-to-test reliability was better in the BP (CV ¼ 1.7%) than in HW (CV ¼ 2.3%). Iwaoka et al (1998) reported comparable results (CV for BP ¼ 3.7%, CV for HW ¼ 4.3%) following a similar protocol. Intradevice reliability of the BP is similar to that reported for DXA (Jensen et al, 1993) . Although intradevice reliability has been evaluated for the BP, interdevice reliability is virtually unknown. In the only relevant study, Collins et al (2004) compared between-laboratory precision of body volume via the BP, however, this analysis included biological and environmental variability due to transportation time between the laboratories, rendering the variability of the actual device to be undefined. Interdevice reliability is crucial for determining overall validity and has practical implications for multicenter studies, intersite testing and acceptance as a reference method for body composition.
The purpose of this study is therefore to evaluate the interdevice reliability of the BP by comparing Db and %BF estimates from two BP units, and to further examine potential contributing factors to the interdevice variability.
Methods

Subjects
A total of 50 healthy adult subjects (26 male, 24 female) varying widely in age and body weight participated in this study (Table 1) . The experimental procedures were approved by the Human Subjects Institutional Review Board of the University of Missouri. All subjects gave written, informed consent prior to data collection.
Study protocol
Duplicate body composition tests were performed on each subject using two different BP units (Life Measurement, Inc., Concord, CA, USA) on the same day. One of the BP units was manufactured in June 2001 (BP1) and the other in July 2002 (BP2). Both BP units were placed in the same room and each had one designated operator. Each operator previously completed training from the manufacturer of the BP. The testing room had one door and no windows. The room temperature was set at 721. The door remained shut during all tests to avoid any influence of air currents. Care was taken so that both operators used the exact same testing procedure and language when explaining the test. Each BP was evaluated according to the standard quality-control procedures as recommended by the manufacturer prior to any daily testing. Subjects avoided eating, drinking or exercising up to 4 h before they arrived at the testing site. All subjects were tested wearing minimal clothing according to the manufacturer's instructions (ie, tight fitting swimsuits or spandex shorts and a lycra swim cap). Two body composition tests were performed in immediate succession (within 5 min of each other). In order to avoid any learning effect, one-half of the subjects entered BP1 first and one-half entered BP2 first. Thoracic gas volume (TGV) was measured and accounted for in each body composition test.
BOD POD
A detailed description of the physical design and operating principles of the BP is provided elsewhere (Dempster & Aitkens, 1995) . Briefly, the BP is a dual chambered airdisplacement plethysmograph that employs the densitometric approach to assess body composition. Subject mass is measured using an electronic scale, which is calibrated to within 70.05%. Subject body volume is measured in an enclosed chamber utilizing the relationship between pressure and volume. Chamber air volume is determined both with and without the subject seated in the test chamber, with the difference between the two measures yielding the subject's body volume. A two-point calibration precedes each test to account for environmental factors. Body volume was measured at least twice and in some cases a third measurement was made if the first two measurements were not within 150 ml or 0.3%. The average of the two values that Table 1 Subject characteristics and percent body fat (%BF) measured by BOD POD 1 (BP1) and BOD POD 2 (BP2) agreed within 150 ml or 0.3% was used in subsequent calculation. On two occasions, no two measurements met the acceptance criteria, and the entire test procedure was repeated. TGV was measured by asking subjects to breathe through a disposable tube that was attached to the inside chamber. Following several normal breathing cycles, the airway in the tube was occluded at which time the subjects were instructed to pant three times by contracting the diaphragm. Merit scores of 41.0 and/or airway pressures 435 cm water indicated poor compliance and subjects were asked to repeat the maneuver. Three subjects were unable to complete the maneuver correctly after five attempts and therefore a predicted TGV was used for both devices. Lastly, body volume was corrected for TGV and surface area artifact, as described previously (Dempster & Aitkens, 1995) . Body density (Db) was then calculated by dividing body mass by corrected body volume, and %BF was derived by using the two-compartment Siri equation (Siri, 1961) . All calculations were performed by the BP's software (version 1.69).
Statistical analysis
Data were analyzed using SPSS version 10.0 and SYSTAT 10.0 (SPSS, Inc., Chicago, IL, USA). Values were expressed as mean7s.d. unless otherwise stated. The within-subject coefficient of variation (CV) for %BF estimates from the two BP units was calculated to indicate interdevice reliability. Repeated measures ANOVA, with gender as a betweensubject factor, was performed to examine differences in Db and %BF between the two BP units, and to determine whether there was a gender difference in the relationship between Db and %BF estimates by BP1 and BP2. When no gender difference in the relationship was found, paired t-tests were used to compare the Db and %BF values between BP1 and BP2 with genders combined. When a significant gender difference was found, Db and %BF estimates from BP1 and BP2 were compared for each gender separately. Agreement of %BF estimates between BP1 and BP2 was assessed using linear regression and Bland-Altman analyses. Linear regression analysis was performed to determine whether the regression line differed significantly from the line of identity, using a simultaneous test of slope and intercept. For Bland-Altman analysis, the differences between the two BP measurements were plotted against the mean values for the two measurements, and the plot was examined for trends across the range of %BF. In addition, the contribution of the differences between the two BP units from subjects' characteristics, such as body mass, height, and age, was assessed by multiple regression analysis. One-way ANOVA was performed to examine whether the differences in %BF between the two BP units were influenced by body mass index (BMI) categorization level (BMI o24.9 kg/m 2 as normal weight, 25.0-29.9 kg/m 2 as overweight, and BMI Z30 kg/m 2 as obese). For all tests, P-values o0.05 were considered to be significant.
Results
The physical characteristics and group mean estimates of Db and %BF are presented in Table 1 . Db and the corresponding %BF estimates by BP1 and BP2 were highly correlated (r40.98, Po0.001). Mean Db estimates by BP1 and BP2 were 1.04070.017 and 1.03970.017 g/ml, respectively, for all subjects. Further analysis showed that the relationship between Db estimates by BP1 and BP2 was marginally but significantly affected by gender (P ¼ 0.04). Db between BP1 and BP2 did not differ significantly for men (DDb ¼ 0.000370.0008 g/ml, P ¼ 0.632), while for women, there was a small but significant difference in Db between BP1 and BP2 (DDb ¼ 0.001870.0003 g/ml, P ¼ 0.001). This resulted in a non-significant difference in %BF between BP1 and BP2 for men (D%BF ¼ 0.171.3, P ¼ 0.665), but a significant %BF difference for women (D%BF ¼ 0.871.1, P ¼ 0.001). The within-subject CV for %BF estimates from the two BP units were 3.072.0% for all subjects, and were 3.472.0 and 2.572.0% for men and women, respectively. Linear regression and Bland-Altman analyses of %BF estimates obtained from BP1 and BP2 (Figure 1 ) indicated a good agreement between the two BP units. The regression lines for both men and women (panels a and c) did not differ significantly from the line of identity (Y ¼ X), and the regression equations indicated a low s.e.e. (1.23 %BF for men and 1.13 %BF for women) and a high R 2 (0.95 for men and 0.97 for women). Individual variations in %BF between BP1 and BP2 were within acceptable ranges (panels b and d, 95% limits of agreement ¼ À2.5-2.7 %BF for men; À1.4-3.0 %BF for women). There was no trend in individual differences between %BF estimates by BP1 and BP2 as %BF varied (r ¼ À0.19, P ¼ 0.359 for men; r ¼ 0.09, P ¼ 0.677 for women). Furthermore, for either gender or with both genders combined, %BF differences between the two BP units were not significantly influenced by BMI categorization levels (P ¼ 0.770). Other subject characteristics, including age, body mass, and height, did not significantly contribute to the differences in %BF estimates by the two BP units.
Discussion
This study presents the first evaluation of interdevice reliability of the BP for body composition assessment in an adult population within the same laboratory. The study results indicate good agreement for both group and individual estimates of %BF obtained from the two BP units. Although the mean differences for women (0.8 %BF) and for all subjects (0.5 %BF) had reached statistical significance, such small differences are not clinically significant. Further analysis using the Bland-Altman technique showed no significant trend for individual differences in %BF between the two BP units relative to the range of %BF. In addition, there were no significant effects of age, body mass, height, and BMI categorization levels (ie, normal weight vs overweight vs obese) on the differences in %BF estimates between the two BP units.
A disparity related to gender did exist. There was a significant difference in %BF estimates between BP1 and BP2 for women (0.8 %BF), but not for men (0.1 %BF), indicating a higher interdevice variability of the BP in %BF estimates for women compared to men. The reason for this disparity is not clear. A possible explanation is that a relatively higher variance in body fatness for women (range 13-43 %BF; s.d. ¼ 6.4) compared to men (range 12-32 %BF; s.d. ¼ 5.7) may result in a possibly higher random error of %BF estimates. Nevertheless, the magnitude of the difference in %BF between the two BP units for either men or women appears not to be clinically significant (0.8 vs 0.1%BF).
In a similar study to the present, Collins et al (2004) found that the interdevice reliability between BP units in separate laboratories was acceptable. However, the study observed relatively large 95% limits of agreement (À3.7 to 2.5 %BF), indicating that practitioners should heed caution when using two different units. Collins et al (2004) pointed out that some of their observed difference between units could be due to environmental differences between laboratories and/or the effects of time between tests, not necessarily differences between the BP units themselves. The current study is unique in that we controlled for these factors by placing two identical units in the same room under the exact same environmental conditions and by completing successive tests (same subject) within 5 min of each other. We found that in only a few individuals (seven out of 50), %BF differences between the two BP units were slightly more than 72 %BF. The current study is also distinct in that TGV was measured. Collins et al (2004) used a predicted value for TGV, resulting in a constant value between both BP units. TGV is a factor in the calculation of Db:
where Vbraw is the raw body volume, SAA is the surface area artifact, and TGV is the thoracic gas volume. The BP allows for either a measured, predicted, or entered TGV, and the manufacture suggests that it be measured when possible. While it was reported by McCrory et al (1998) that TGV did not significantly impact %BF in adults, other studies presented a significant impact on %BF when measured or predicted TGV was used, especially in Children (Demerath et al, 2002; Buchholz et al, 2004 ). In the current study, we found that the agreement in measured TGV values between the two BP units (r 2 ¼ 0.98, Po0.001) was as good as the agreement in repeated measurements of TGV by a single BP (r 2 ¼ 0.95, Po0.001) (Collins & McCarthy, 2003) . In order to make a direct comparison in interdevice reliability with that from Collins et al (2004) , we reassessed interdevice reliability by comparing %BF estimates from the two BP units using predicted TGV. The agreement in %BF estimates between the two BP units, in terms of mean difference (0.571.2 %BF), 95% limits of agreements (À1.9-2.9 %BF) and within-subject CV (3.172.2%), was found to be better than that observed by Collins et al (2004) , and was similar to that calculated using measured TGV in this study. Previous studies have reported that intradevice reliability, as indicated by within-subject CV for repeated %BF measurements by a single BP, ranged from 1.7 to 3.7% within a day (McCrory et al, 1995; Iwaoka et al, 1998) , and from 2.0 to 2.3% between days (Levenhagen et al, 1999; Miyatake et al, 1999) for adults. A comparison of these CVs with those obtained from the current study indicates that the BP has a similar intra and interdevice reliability for assessing %BF. These results suggest that the majority of the reported variability is most likely due to inherent technological and biological factors as opposed to variation in manufacturing. It appears that interdevice reliability has been minimized through consistent manufacturing practices, implying that reliability between BP units is similar to the reliability within the same BP.
The body composition estimation of %BF using the BP is based on the measurement of body mass, body volume and TGV as previously described by Dempster and Aitkens (1995) . Of these three measurements, we found that the body volume measurement appears to contribute to the largest source of difference in %BF estimates between the two BP units. The 54 ml difference in mean body volume between BP1 and BP2 explained 81% of the total difference in %BF, while the difference in body mass and TGV explained 13 and 6%, respectively. We suspect that the difference in body volume measurements is most likely a combination of mechanical and physiological changes. Possible physiological sources of error include subject positioning, breathing rate/pattern, and perspiration. Mechanical sources of error are most likely related to repeatability of door closure and rigidity of the chamber shell.
Although HW has been accepted as a reference standard, very little information is available on intersystem reliability to compare our results with. Since there is a lack of a standardized HW system and protocol, such a study would need to test the wide range of laboratory instrumentation and protocols that exist with HW. In the most comprehensive evaluation available, Lohman (1992) reported a standard deviation in Db of 0.0015 g/ml for two individuals measured by HW at five different laboratories following the same protocol. However, these results may not represent the true reliability between HW systems due to the wide range of equipment and protocols commonly used in laboratories such as selection and number of trials, equipment for measuring underwater weight (autopsy scale vs load cells), subject position, calibration, and method for determining residual lung volume (simultaneous vs separate, underwater vs land, helium vs oxygen dilution). Of these, differences in residual volume determination (Girandola et al, 1977; Morrow et al, 1986) and trial selection criteria (Katch, 1968; Bonge & Donnelly, 1989) have been reported to contribute the largest sources of variation.
DXA is also commonly used as a reference standard for the assessment of body composition. Although currently not considered a 'gold standard', DXA is frequently regarded as a possible successor to HW. However, several uncertainties still persist in regard to the interdevice reliability of DXA for measuring soft tissue. Significant differences in %BF estimates (3-6 %BF) were observed between three commercial DXA systems (Hologic, Lunar and Norland) (Tothill et al, 1994) , indicating that DXA systems from different manufacturers may not be interchangeable without cross-calibration. Several studies have also demonstrated significant differences in the estimates of %BF between test modes (ie, pencil beam vs fan beam) (Ellis & Shypailo, 1998; Tylavsky et al, 2000; Tothill et al, 2001) , and between software versions (Van Loan et al, 1995) . To our knowledge, there have been no recent studies (o5 y) that have investigated %BF estimates between two identical DXA machines of the most recent model and most current software package. Previous studies (Paton et al, 1995; Tataranni et al, 1996) have illustrated discrepancies (5.3 and 1.7 %BF). This may indicate that even identical models of DXA from the same manufacturer may not provide comparable body composition estimates. Interdevice evaluation of the newer DXA models and software packages are needed.
As we continue to develop and validate new methods, we must take into consideration how interdevice/system variation influences the results of comparative studies. We must acknowledge that even the reference methods contribute their own error due to method related assumptions, technical/operator error, subject compliance, protocol, and especially intra and interdevice variability. As we quantify these sources, we will improve our estimates of the 'true' error of the available techniques.
This study is not without its own limitations. Future studies should compare multiple BP units, further analyze any gender effect, and include direct comparisons of the intradevice reliability using the same subjects. Ideally, such studies would evaluate other reference methods in comparison. In conclusion, no clinically significant difference existed in %BF estimates between the BP units, and it appears the interdevice variability of the BP has minimal impact on %BF estimates. Further, test-to-test reliability between BP units appears to be as good as within one unit, and also appears to be as good, if not better than other available body composition methods.
